|CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer|
M Griffith, NC Spies, K Krysiak, JF McMichael, AC Coffman, AM Danos, ...
Nature genetics 49 (2), 170-174, 2017
|DGIdb 2.0: mining clinically relevant drug–gene interactions|
AH Wagner, AC Coffman, BJ Ainscough, NC Spies, ZL Skidmore, ...
Nucleic acids research 44 (D1), D1036-D1044, 2016
|Optimizing cancer genome sequencing and analysis|
M Griffith, CA Miller, OL Griffith, K Krysiak, ZL Skidmore, A Ramu, ...
Cell systems 1 (3), 210-223, 2015
|NeoPalAna: neoadjuvant palbociclib, a cyclin-dependent kinase 4/6 inhibitor, and anastrozole for clinical stage 2 or 3 estrogen receptor–positive breast cancer|
CX Ma, F Gao, J Luo, DW Northfelt, M Goetz, A Forero, J Hoog, ...
Clinical Cancer Research 23 (15), 4055-4065, 2017
|GenVisR: genomic visualizations in R|
ZL Skidmore, AH Wagner, R Lesurf, KM Campbell, J Kunisaki, OL Griffith, ...
Bioinformatics 32 (19), 3012-3014, 2016
|A phase I trial of BKM120 (Buparlisib) in combination with fulvestrant in postmenopausal women with estrogen receptor–positive metastatic breast cancer|
CX Ma, J Luo, M Naughton, F Ademuyiwa, R Suresh, M Griffith, OL Griffith, ...
Clinical Cancer Research 22 (7), 1583-1591, 2016
|Genome modeling system: a knowledge management platform for genomics|
M Griffith, OL Griffith, SM Smith, A Ramu, MB Callaway, AM Brummett, ...
PLoS computational biology 11 (7), e1004274, 2015
|A phase II trial of neoadjuvant MK-2206, an AKT inhibitor, with anastrozole in clinical stage II or III PIK3CA-mutant ER-positive and HER2-negative breast cancer|
CX Ma, V Suman, MP Goetz, D Northfelt, ME Burkard, F Ademuyiwa, ...
Clinical Cancer Research 23 (22), 6823-6832, 2017
|The prognostic effects of somatic mutations in ER-positive breast cancer|
OL Griffith, NC Spies, M Anurag, M Griffith, J Luo, D Tu, B Yeo, J Kunisaki, ...
Nature communications 9 (1), 1-16, 2018
|Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer|
AH Wagner, S Devarakonda, ZL Skidmore, K Krysiak, A Ramu, L Trani, ...
Nature communications 9 (1), 1-11, 2018
|Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade|
DA Rauch, KC Conlon, M Janakiram, JE Brammer, JC Harding, BH Ye, ...
blood 134 (17), 1406-1414, 2019
|Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples|
EK Barnell, P Ronning, KM Campbell, K Krysiak, BJ Ainscough, LM Sheta, ...
Genetics in Medicine 21 (4), 972-981, 2019
|Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia|
M Griffith, OL Griffith, K Krysiak, ZL Skidmore, MJ Christopher, JM Klco, ...
Experimental hematology 44 (7), 603-613, 2016
|Melorheostosis: exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS|
MP Whyte, M Griffith, L Trani, S Mumm, GS Gottesman, WH McAlister, ...
Bone 101, 145-155, 2017
|A genomic case study of mixed fibrolamellar hepatocellular carcinoma|
OL Griffith, M Griffith, K Krysiak, V Magrini, A Ramu, ZL Skidmore, ...
Annals of Oncology 27 (6), 1148-1154, 2016
|A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML|
K Krysiak, MJ Christopher, ZL Skidmore, RT Demeter, V Magrini, ...
Blood cancer journal 6 (4), e413-e413, 2016
|A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion|
CA Miller, C Tricarico, ZL Skidmore, GL Uy, YS Lee, A Hassan, ...
Blood advances 2 (11), 1295-1299, 2018
|Truncating prolactin receptor mutations promote tumor growth in murine estrogen receptor-alpha mammary carcinomas|
OL Griffith, SR Chan, M Griffith, K Krysiak, ZL Skidmore, J Hundal, ...
Cell reports 17 (1), 249-260, 2016
|RegTools: Integrated analysis of genomic and transcriptomic data for discovery of splicing variants in cancer|
YY Feng, A Ramu, KC Cotto, ZL Skidmore, J Kunisaki, DF Conrad, Y Lin, ...
bioRxiv, 436634, 2018
|Oral cavity squamous cell carcinoma xenografts retain complex genotypes and intertumor molecular heterogeneity|
KM Campbell, T Lin, P Zolkind, EK Barnell, ZL Skidmore, AE Winkler, ...
Cell reports 24 (8), 2167-2178, 2018